Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
Open accessAbstract
High-grade gliomas (World Health Organization grade III anaplastic astrocytoma and grade IV glioblastoma multiforme), the most prevalent primary malignant brain tumors, display a cellular hierarchy with self-renewing, tumorigenic cancer stem cells (CSCs) at the apex. While the CSC hypothesis has been an attractive model to describe many aspects of tumor behavior, it remains controversial due to unresolved issues including the use of ex vivo analyses with differential growth conditions. A CSC population has been confirmed in malignant gliomas by preferential tumor formation from cells directly isolated from patient biopsy specimens. However, direct comparison of multiple tumor cell populations with analysis of the resulting phenotypes of each population within a representative tumor environment has not been clearly described. To directly test the relative tumorigenic potential of CSCs and non-stem tumor cells in the same microenvironment, we interrogated matched tumor populations purified from a primary human tumor transplanted into a xenograft mouse model and monitored competitive in vivo tumor growth studies using serial in vivo intravital microscopy. While CSCs were a small minority of the initial transplanted cancer cell population, the CSCs, not the non-stem tumor cells, drove tumor formation and yielded tumors displaying a cellular hierarchy. In the resulting tumors, a fraction of the initial transplanted CSCs maintained expression of stem cell and proliferation markers, which were significantly higher compared to the non-stem tumor cell population and demonstrated that CSCs generated cellular heterogeneity within the tumor. These head-to-head comparisons between matched CSCs and non-stem tumor cells provide the first functional evidence using live imaging that in the same microenvironment, CSCs more than non-stem tumor cells are responsible for tumor propagation, confirming the functional definition of a CSC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glioblastoma tumors contain a diverse mixture of growing, senescent, quiescent, and dying cells.
“GBM tumors are known to harbor an exceptionally diverse admixture of growing, senescent, quiescent, and dying cells16, 17.”
From Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate (2016) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 35 · Cited by 158
- Authors
- Lathia, J. D., Gallagher, J., Myers, J. T., Li, M., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., Huang, A. Y., & Rich, J. N.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Duke Medical Center (US)
- Corresponding author
- Lathia, Justin D.
- Rich, Jeremy N.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-22
- Volume
- 6
- Issue
- 9
- Pages
- e24807
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3178553
- OpenAlex
- W2141339467
- Cited by
- 158
- References
- 35
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 8 · 2021: 10 · 2020: 11 · 2019: 11 · 2018: 10 · 2017: 10 · 2016: 9 · 2015: 19 · 2014: 17 · 2013: 18 · 2012: 9
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Cancer Research Institute
- James S. McDonnell Foundation
- Damon Runyon Cancer Research Foundation
- Dana Foundation
- National Brain Tumor Society
- Pediatric Brain Tumor Foundation
- Eli Lilly and Company
- St. Baldrick's Foundation
- Cleveland Clinic
- Cleveland Clinic Foundation
- Case Comprehensive Cancer Center, Case Western Reserve University
- National Institutes of Health (5p50ns020023-30)
- National Cancer Institute (CA 116659, R01CA116659, R01CA154656, CA112958, CA151522, F32CA142159, R01CA154130, R01CA151522, CA154130, CA142159)
- National Institute of Neurological Disorders and Stroke (P50-NS020023, 5P50-NS-20023-26)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- glioblastoma, cancer stem cells, tumor propagation, tumor cell hierarchy, intravital microscopy, xenograft mouse model, tumor heterogeneity, stem cell markers, high-grade glioma
- MeSH terms
- AC133 Antigen, Adult, Animals, Blood Vessels, Brain Neoplasms, Glioblastoma, Glycoproteins, Humans, Immunohistochemistry, Luminescent Proteins, Male, Mice, Nude, Neoplasm Transplantation, Peptides, Transplantation, Heterologous, Tumor Cells, Cultured, Neoplastic Stem Cells, Antigens, CD, Microscopy, Fluorescence, Multiphoton, Tumor Burden, Cell Proliferation, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review